CLOVER HEALTH INVESTMENTS, CORP. /DE — Form 8-K
Filed November 4, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 68/100
What the filing says
Clover Health reported Q3 2026 GAAP net income of $6.4M (vs. loss of $24.4M YoY) and 9M YTD GAAP net income of $61.8M. Medicare Advantage membership reached 158,907 (45% YoY growth). The company raised full-year 2026 guidance: revenues to $2.97–$3.00B (vs. $2.92–$3.00B prior), GAAP net income to $25–$35M (vs. $20–$35M), and Adjusted EBITDA to $75–$85M (vs. $70–$85M). Consolidated gross profit guidance increased to $540–$555M.
Why this rating
Strong profitability turnaround and membership growth at ~6% of market cap; guidance raises modest but meaningful given path to first full-year profitability.
See more from November 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.